No HeadingPurpose.The aim of this study is to compare the accuracy of five methods for predicting in vivo intrinsic clearance (CLint) and seven for predicting hepatic clearance (CLh) in humans using in vitro microsomal data and/or preclinical animal data.Methods.The human CLint was predicted for 33 drugs by five methods that used either in vitro data with a physiologic scaling factor (SF), with an empirical SF, with the physiologic and drug-specific (the ratio of in vivo and in vitro CLint in rats) SFs, or rat CLint directly and with allometric scaling. Using the estimated CLint, the CLh in humans was calculated according to the well-stirred liver model. The CLh was also predicted using additional two methods: using direct allometric scaling or drug-specific SF and allometry.Results.Using in vitro human microsomal data with a physiologic SF resulted in consistent underestimation of both CLint and CLh . This bias was reduced by using either an empirical SF, a drug-specific SF, or allometry. However, for allometry, there was a substantial decrease in precision. For drug-specific SF, bias was less reduced, precision was similar to an empirical SF. Both CLint and CLh were best predicted using in vitro human microsomal data with empirical SF. Use of larger data set of 52 drugs with the well-stirred liver model resulted in a best-fit empirical SF that is 9-fold increase on the physiologic SF.Conclusions.Overall, the empirical SF method and the drug-specific SF method appear to be the best methods; they show lower bias than the physiologic SF and better precision than allometric approaches. The use of in vitro human microsomal data with an empirical SF may be preferable, as it does not require extra information from a preclinical study.

Prediction of human drug clearance from in vitro and preclinical data using physiological-based and empirical approaches.

A scoping review of the health and toxicological activity of bisphenol A (BPA) structural analogues and functional alternatives

Characterization of Estrogenic and Androgenic Activities for Bisphenol A-like Chemicals (BPs): In Vitro Estrogen and Androgen Receptors Transcriptional Activation, Gene Regulation, and Binding Profiles.

Background: Available toxicity data can be optimally interpreted if they are integrated using computational approaches such as systems biology modeling. Such approaches are particularly warranted i...

https://hal.archives-ouvertes.fr/hal-02196330/document

Linking Bisphenol S to Adverse Outcome Pathways Using a Combined Text Mining and Systems Biology Approach.

Toxicokinetics of bisphenol A, bisphenol S, and bisphenol F in a pregnancy sheep model.

Background: The endocrine disrupting chemical bisphenol A (BPA) has been facing stricter regulations in recent years BPA analogs, such as the bisphenols S, F, and AF (BPS, BPF, and BPAF) are incre

Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes.

Cecile Karrer

Papers

Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes.